Biological Variation Database specifications

 

The within- and between-subject components of variation, expressed in coefficients of variation (CVw and CVg, respectively) and the corresponding quality specifications for analytical imprecision (I), bias (B) and total error (TE), expressed in percentages, were calculated according the following formulas:

I < 0.5 CVw

B < 0.25 (CVw2 + CVg2)1/2

TE<k.I+B soit TE < k. 0.5 CVw+ 0.25(CVw2 + CVg2)1/2 being k= 1.65 at a=0.05,

Note on abbreviations:
CVw = within-subject biologic variation (intraindivid)

CVg = between-subject biologic variation (:interindivi)

I = desirable specification for imprecision (:infidelite)

B = desirable specification for inaccuracy (: biais)

TE = desirable specification for allowable total error (erreur totale)


Analyte Biological
Variation
Desirable
specification

CVw

:intraindivid

CVg

:interindivi

I(%)

:infidelite

B(%)

: biais

TE(%)

erreur totale

S- 11-Desoxycortisol 21.3 31.5 10.7 9.5 27.1
S- 17-Hydroxyprogesterone 19.6 52.4 9.8 14.0 30.2
U- 4 OH-3 methoxi-Vanil mandelic acid (VMA) 22.2 47.0 11.1 13.0 31.3
S- 5' Nucleotidase 11.3 12.6 5.7 4.2 13.6
U- 5'-Hydroxyindolacetate, concentration 20.3 33.2 10.2 9.7 26.5
S- a1-Acid Glycoprotein 11.3 24.9 5.7 6.8 16.2
S- a1-Antichymotrypsin 13.5 18.3 6.8 5.7 16.8
S- a1-Antitrypsin 5.9 16.3 3.0 4.3 9.2
S- a1-Globulin 11.4 22.6 5.7 6.3 15.7
U- a1-Microglobulin, concentration, first morning 33.0 58.0 16.5 16.7 43.9
P- a2-Antiplasmin 6.2 --- 3.1 --- ---
S- a2-Globulins 10.3 12.7 5.2 4.1 12.6
S- a2-Macroglobulin 3.4 18.7 1.7 4.8 7.6
U- a2-Microglobulin output, first morning
29.0 32.0 14.5 10.8 34.7
S- a-Amylase 8.7 28.3 4.4 7.4 14.6
S- a-Amylase (pancreatic) 11.7 29.9 5.9 8.0 17.7
U- a-Amylase concentration, random 94.0 46.0 47.0 26.2 103.7
S- a-Carotene 35.8 65.0 17.9 18.6 48.1
S- a-Fetoprotein(non hepatic carcinoma) 12.0 46.0 6.0 11.9 21.8
S- a-Tocopherol 13.8 15.0 6.9 5.1 16.5
S- Acid phosphatase 8.9 8.0 4.5 3.0 10.3
S- Acid phosphatase tartrate-resistant (TR-ACP) 8.0 13.3 4.0 3.9 10.5
S- Acid phosphatase prostatic activity (PAP) 33.8 --- 16.9 --- ---
P- Activated partial thromboplastine time 2.7 8.6 1.4 2.3 4.5
S- Acyl/free carnitine 10.4 27.2 5.2 7.3 15.9
P- Adiponectin 18.8 51.2 9.4 13.6 29.1
S- Adenosine deaminase (ADA) 11.7 25.5 5.9 7.0 16.7
S- Alanine aminopeptidase 4.1 --- 2.1 --- ---
S- Alanine aminotransferase 24.3 41.6 12.2 12.0 32.1

Note on abbreviations:
CVw = within-subject biologic variation
CVg = between-subject biologic variation
I = desirable specification for imprecision
B = desirable specification for inaccuracy
TE = desirable specification for allowable total error


 

Analyte Biological
Variation
Desirable
specification

CVw

:intraindivid

CVg

:interindivi

I(%)

:infidelite

B(%)

: biais

TE(%)

erreur totale

S- Albumin 3.1 4.2 1.6 1.3 3.9
U- Albumin, concentration, first morning 36.0 55.0 18.0 16.4 46.1
S- Aldosterone 29.4 40.1 14.7 12.4 36.7
U- Aldosterone, concentration 32.6 39.0 16.3 12.7 39.6
S- Alkaline phosphatase 6.4 24.8 3.2 6.4 11.7
S- Alkaline phosphatase, bone 6.2 35.6 3.1 9.0 14.1
S- Alkaline phosphatase, liver 10.0 27.0 5.0 7.2 15.4
S- Alkaline phosphatase, placental 19.1 --- 9.6 --- ---
U- Ammonia, output, 24h
24.7 27.3 12.4 9.2 29.6
S- Amyloid A 25.0 61.0 12.5 16.5 37.1
S- Androstendione 11.1 51.1 5.6 13.1 22.2
S- Androstenedione 11.1 51.1 5.8 13.1 22.6
P- Angiotensin converting enzyme 0.1 --- 0.1 --- ---
P- Antithrombin III 5.2 15.3 2.6 4.0 8.3
S- Apolipoprotein A1 6.5 13.4 3.3 3.7 9.1
S- Apolipoprotein B 6.9 22.8 3.5 6.0 11.6
S- Ascorbic Acid 26.0 31.0 13.0 10.1 31.6
S- Aspartate aminotransferase 11.9 17.9 6.0 5.4 15.2
S- b-2-Microglobulin 5.9 15.5 3.0 4.1 9.0
S- Basophile, count 28.0 54.8 14.0 15.4 38.5
S- b-Carotene 36.0 39.7 18.0 13.4 43.1
S- b-Cryptoxantin 36.7 --- 18.4 --- ---
S- b-Globulins 10.1 9.1 5.1 3.4 11.7
S- Bilirubin total 23.8 39.0 11.9 11.4 31.1
S- Bilirubin conjugated 36.8 43.2 18.4 14.2 44.5
S- CA 125 antigen 24.7 54.6 12.4 15.0 35.4
S- CA 15.3 antigen 6.1 62.9 3.1 15.8 20.8
S- CA 19.9 antigen 16.0 102.0 8.0 25.8 39.0
S- CA 549 antigen 9.1 33.4 4.6 8.7 16.2

Note on abbreviations:
CVw = within-subject biologic variation
CVg = between-subject biologic variation
I = desirable specification for imprecision
B = desirable specification for inaccuracy
TE = desirable specification for allowable total error


 

Analyte Biological
Variation
Desirable
specification

CVw

:intraindivid

CVg

:interindivi

I(%)

:infidelite

B(%)

: biais

TE(%)

erreur totale

S- Calcium 1.9 2.8 1.0 0.8 2.4
U- Calcium, concentration, 24h 27.5 36.6 13.8 11.4 34.1
U- Calcium, ionized 1.7 1.9 0.9 0.6 2.0
U- Calcium, output, 24h 26.2 27.0 13.1 9.4 31.0
S- Carbohydrate deficient transferrin 7.1 38.7 3.6 9.8 15.7
S- Carcinoembryonic antigen (CEA) 12.7 55.6 6.4 14.3 24.7
B- CD4 lymphocyte count 25.0 --- 12.5 --- ---
S- Ceruloplasmin 5.8 11.1 2.9 3.1 7.9
S- Chloride 1.2 1.5 0.6 0.5 1.5
S- Cholesterol 5.4 15.2 2.7 4.0 8.5
S- Cholinesterase 7.0 10.4 3.5 3.1 8.9
S- Cholinesterase, activity 5.4 10.3 2.7 2.9 7.4
S- Cholinesterase, immunoreactive 6.4 --- 3.2 --- ---
S- C3 complement 5.2 15.6 2.6 4.1 8.4
S- C4 complement 8.9 33.4 4.5 8.6 16.0
P- Chromogranin A 12.8 26.3 6.4 7.3 17.9
P- Copper 8.0 19.0 4.0 5.2 11.8
S- Copper 4.9 13.6 2.5 3.6 7.7
S- Cortisol 20.9 45.6 10.5 12.5 29.8
S- C Peptide 16.6 23.2 8.3 7.1 20.8
S- C-Propeptide type I procollagen 8.2 17.6 4.1 4.9 11.6
S- C-Reactive protein 42.2 76.3 21.1 21.8 56.6
U- C-Terminal cross-linking telopeptide  type I collagen (s-CTx) 9.6 30.6 4.8 8.0 15.9
U- C-Telopeptide of type I collagen/creatinine, 1st morning 32.8 48.0 16.4 14.5 41.6
U- C-Telopeptide type I collagen/creatinine, 2nd morning 23.4 --- 11.7 --- ---
S- Creatine kinase (CK) 22.8 40.0 11.4 11.5 30.3
S- Creatine kinase MB, % 6.9 48.2 3.45 12.17 17.87
S- Creatine kinase MB, activity 19.7 24.3 9.9 7.8 24.1
S- Creatine kinase MB, mass 18.4 61.2 9.2 16.0 31.2
S- Creatinine 5.3 14.2 2.7 3.8 8.2
Patient- Creatinine clearance 13.6 13.5 6.8 4.8 16.0
U- Creatinine, concentration, 24h
24.0 24.5 12.0 8.6 28.4
U- Creatinine, output, 24h 11.0 23.0 5.5 6.4 15.4
S- Cyfra 21.1 22.5 31.1 11.3 9.6 28.2
S- Cystastin C 4.6 13.0 2.3 3.4 7.2
P- Cysteine 5.9 12.3 3.0 3.4 8.3
U- ?-aminolevulinic acid 16.0 27.0 8.0 7.8 21.0

Note on abbreviations:
CVw = within-subject biologic variation
CVg = between-subject biologic variation
I = desirable specification for imprecision
B = desirable specification for inaccuracy
TE = desirable specification for allowable total error


 

Analyte Biological
Variation
Desirable
specification

CVw

:intraindivid

CVg

:interindivi

I(%)

:infidelite

B(%)

: biais

TE(%)

erreur totale

S- Dehydroepiandrosterone sulfate 4.2 29.3 2.1 7.4 10.9
U- Deoxypyridinoline/creatinine, 24h (Delmas CC 2001)
13.5 17.6 6.8 5.5 16.7
U- Deoxypyridinoline/creatinine, first morning 13.1 19.0 6.6 5.8 16.6
U- Deoxipyridinoline/minute 26.5 35.7 13.3 11.1 33.0
P- Dipeptidyl-peptidase IV (ACE) 8.2 14.5 4.1 4.2 10.9
S- Dipeptidyl-peptidase IV (ACE) 12.5 27.7 6.3 7.6 17.9
P- Elastase 13.6 16.4 6.8 5.3 16.5
S- Endotelial growth factor 10.7 47.6 5.4 12.2 21.0
B- Eosinophils, count 21.0 76.4 10.5 19.8 37.1
(B)Plat- Epinephrine 25.3 --- 12.7 --- ---
P- Epinephrine 48.3 --- 24.2 --- ---
B- Erythrocytes, count 3.2 6.1 1.6 1.7 4.4
B- Erythrocyte distribution wide 3.5 5.7 1.8 1.7 4.6
U- Estradiol 30.4 --- 15.2 --- ---
S- Estradiol 18.1 19.7 9.1 6.7 21.6
P- Factor V coagulation 3.6 --- 1.8 --- ---
P- Factor VII coagulation 6.8 19.4 3.4 5.1 10.7
P- Factor VIII coagulation 4.8 19.1 2.4 4.9 8.9
P- Factor X coagulation 5.9 --- 3.0 --- ---
S- Ferritin 14.2 15.0 7.1 5.2 16.9
P- Fibrinogen 10.7 15.8 5.4 4.8 13.6
(B)Erthry- Folate 12.0 66.0 6.0 16.8 26.7
S- Folate 24.0 73.0 12.0 19.2 39.0
S- Follicle stimulating hormone (males) 8.7 18.0 4.4 5.0 12.2
S- Free carnitine 7.6 15.2 3.8 4.2 10.5
S- Free estradiol 22.8 --- 11.4 --- ---
U- Free estradiol 38.6 --- 19.3 --- ---
S- Free testosterone 9.3 --- 4.7 --- ---
U- Free testosterone 51.7 --- 25.9 --- ---
S- Free thyroxine (FT4) 5.7 12.1 2.9 3.3 8.0
S- Free Triiodothyronine (FT3) 7.9 17.6
4.0 4.8 11.3
S- Fructosamine 3.4 5.9 1.7 1.7 4.5
S- Galactosyl hydroxylisine 11.8 25.8 5.9 7.1 16.8
S- g-Globulins 14.6 12.3 7.3 4.8 16.8
S- g-glutamyltransferase 13.8 41.0 6.9 10.8 22.2
S- Globulins, total 5.5 12.9 2.8 3.5 8.0
S- Glucose 5.7 6.9 2.9 2.2 6.9
(B)Erythr- Glucose-6-phosphate-1-dehydrogenase (G6PDH)
32.8 31.8 16.4 11.4 38.5
B - spot Glucose-6-phosphate-1-dehydrogenase (G6PDH) 7.3 10.3 3.7 3.2 9.2
S- Glutathion peroxidase 7.2 21.7 3.6 5.7 11.7
S- Glycated albumin 5.2 10.3 2.6 2.9 7.2
S- Glycated total protein 0.9 11.6 0.5 2.9 3.7
P, S- Haptoglobin 20.4 36.4 10.2 10.4 27.3
B- Hematocrit 2.8 6.4 1.4 1.7 4.1
B- Hemoglobin 2.8 6.6 1.4 1.8 4.1
B- Hemoglobin A1 C 3.4 5.1 1.7 1.5 4.3
S- HDL cholesterol 7.1 19.7 3.6 5.2 11.1
S- HDL 1 cholesterol 5.5 27.2 2.8 6.9 11.5
S- HDL 2 cholesterol 15.7 40.7 7.9 10.9 23.9
S- HDL 3 cholesterol 7.0 14.3 3.5 4.0 9.8
P- Homocysteine 9.0 40.3 4.5 10.3 17.7
S- Hydroxyproline/creatinine 25.9 38.0 13.0 11.5 32.9
U- Hydroxyproline/minute, night urine 36.1 38.8 18.1 13.2 43.0
S- Hydroxybutyrate dehydrogenase 8.8 --- 4.4 --- ---

Note on abbreviations:
CVw = within-subject biologic variation
CVg = between-subject biologic variation
I = desirable specification for imprecision
B = desirable specification for inaccuracy
TE = desirable specification for allowable total error


 

Analyte Biological
Variation
Desirable
specification

CVw

:intraindivid

CVg

:interindivi

I(%)

:infidelite

B(%)

: biais

TE(%)

erreur totale

S- Immunoglobulin A 5.4 35.9 2.7 9.1 13.5
S- Immunoglobulin G 4.5 16.5 2.3 4.3 8.0
S- Immunoglobulin M 5.9 47.3 3.0 11.9 16.8
S- Immunoglobulins K chains 4.8 15.3 2.4 4.0 8.0
S- Immunoglobulins l chains 4.8 18.0 2.4 4.7 8.6
S- Insulin 21.1 58.3 10.6 15.5 32.9
S- Insulin-like growth factor (IGF-1) 9.4 27 4.7 7.1 14.9
S- Intercellular adhesion molecule-1 1.9 21.0 1.0 5.3 6.8
(B)Leuc- Interferon receptor 14.0 20.0 7.0 6.1 17.7
S- Interleukin-1B 30.0 36.0 15.0 11.7 36.5
S- Interleukin-8 24.0 31.0 12.0 9.8 29.6
S- Iron 26.5 23.2 13.3 8.8 30.7
B- Lactate 27.2 16.7 13.6 8.0 30.4
S- Lactate dehydrogenase (LDH) 8.6 14.7 4.3 4.3 11.4
S- Lactate dehydrogenase 1 isoform (LDH1) 6.3 10.2 3.2 3.0 8.2
S- Lactate dehydrogenase 2 isoform (LDH2) 4.9 4.3 2.5 1.6 5.7
S- Lactate dehydrogenase 3 isoform (LDH3) 4.8 5.5 2.4 1.8 5.8
S- Lactate dehydrogenase 4 isoform (LDH4) 9.4 9.0 4.7 3.3 11.0
S- Lactate dehydrogenase 5 isoform (LDH5) 12.4 13.4 6.2 4.6 14.8
P- Lactoferrin 11.8 23.7 5.9 6.6 16.4
P- Leukocytes, count 10.9 19.6 5.5 5.6 14.6
S- LDL Cholesterol 8.3 25.7 4.2 6.8 13.6
S- LDL Cholesterol (direct) 6.5 --- 3.3 --- ---
P- LDL Cholesterol (oxidized) 21.0 50.0 10.5 13.6 30.9
S- LDL receptor mRNA 21.5 13.6 10.8 6.4 24.1
B- Leukocytes count 10.9 19.6 5.5 5.6 14.6
S- Lipase 23.1 33.1 11.6 10.1 29.1
S- Lipoprotein (a) 8.5 85.8 4.3 21.6 28.6
S- Lutein 19.5 21.0 9.8 7.2 23.3
S- Luteinizing hormone 14.5 27.8 7.3 7.8 19.8
S- Lycopenene 40.1 33.0 20.1 --- ---
B- Lymphocytes, count 10.4 27.8 5.2 7.4 16.0
B- Lymphocytes CD4 25.0 --- 12.5 --- ---

Note on abbreviations:
CVw = within-subject biologic variation
CVg = between-subject biologic variation
I = desirable specification for imprecision
B = desirable specification for inaccuracy
TE = desirable specification for allowable total error


 

Analyte Biological
Variation
Desirable
specification

CVw

:intraindivid

CVg

:interindivi

I(%)

:infidelite

B(%)

: biais

TE(%)

erreur totale

(B)Erythr- Magnesium 5.6 11.3 2.8 3.2 7.8
(B)Leuc- Magnesium 18.3 16.4 9.2 6.1 21.2
S- Magnesium 3.6 6.4 1.8 1.8 4.8
U- Magnesium, concentration, 24h 45.4 37.4 22.7 14.7 52.2
U- Magnesium, ionized 1.9 5.1 1.0 1.4 2.9
U- Magnesium, output, 24h 38.3 37.6 19.2 13.4 45.0
(B)Erythr- Mean corpuscular hemoglobin (HCM) 1.6 5.2 0.8 1.4 2.7
(B)Erythr- Mean corpuscular hemoglobin concentration (MCHC) 1.7 2.8 0.9 0.8 2.2
(B)Erythr- Mean corpuscular volume (MCV) 1.3 4.8 0.7 1.2 2.3
(B)Plat- Mean platelet volume (MPV) 4.3 8.1 2.2 2.3 5.8
B- Monocytes, count 17.8 49.8 8.9 13.2 27.9
S- Mucinous carcinoma-associated antigen (MCA) 10.1 39.3 5.1 10.1 18.5
S- Myeloperoxidase 36.0 30.0 18.0 11.7 41.4
S- Myoglobin 13.9 29.6 7.0 8.2 19.6
U- N-Acetyl Glucosaminidase, concentration, overnight 48.6 18.4 24.3 13.0 53.1
B- Neutrophyles, count 16.1 32.8 8.1 9.1 22.4
U- Nitrogen, output 13.9 24.2 7.0 7.0 18.4
S- Non-inhibited arilestearase activity 3.8 37.2 1.9 9.3 12.5
B(Plat)- Norepinephrine 9.5 --- 4.8 --- ---
P- Norepinephrine 19.5 --- 9.8 --- ---
U- N- Telopeptide of type I collagen /creatinine, first urine 17.2 44.8 8.6 12.0 26.2
S- N-terminal (NT)-proBNP 20.8 36.2 10.4 10.4 27.6
S- Osmolality 1.3 1.2 0.7 0.4 1.5
S- Osteocalcin 6.3 23.1 3.2 6.0 11.2
S- Osteocalcin (+1 trab) 7.2 27.0 3.6 7.0 12.9
U- Oxalate, concentration, 24h
44.0 18.0 22.0 11.9 48.2
U- Oxalate, output, 24h
42.5 19.9 21.3 11.7 46.8

Note on abbreviations:
CVw = within-subject biologic variation
CVg = between-subject biologic variation
I = desirable specification for imprecision
B = desirable specification for inaccuracy
TE = desirable specification for allowable total error


 

Analyte Biological
Variation
Desirable
specification

CVw

:intraindivid

CVg

:interindivi

I(%)

:infidelite

B(%)

: biais

TE(%)

erreur totale

B- pCO2 4.8 5.3 2.4 1.8 5.7
B- pH [H+] 3.5 2.0 1.8 1.0 3.9
B- pH (pH units) 0.2 --- 0.1 --- ---
S- Paraoxon 13.4 84.0 6.7 21.3 32.3
S- Paraoxonase 1 substrate inhibition (PON 4SI) 3.9 80.1 1.9 20.0 23.2
S- Paraoxonase activity (salt estimulated) 8.0 86.4 4.0 21.7 28.3
S- Parathyroid hormone (PTH) 25.9 23.8 13.0 8.8 30.2
S- Phenylacetate 6.6 25.2 3.3 6.5 12.0
S- Phosphate 8.5 9.4 4.3 3.2 10.2
U- Phosphate, concentration, 24h
26.4 26.5 13.2 9.4 31.1
U- Phosphate, output, 24h
18.0 22.6 9.0 7.2 22.1
Patient- Phosphate tubular reabsorption 2.7 3.3 1.4 1.1 3.3
S- Phospholipids 6.5 11.1 3.3 3.2 8.6
P- Plasminogen 7.7 --- 3.9 --- ---
B- Platelets, count 9.1 21.9 4.6 5.9 13.4
B- Platelet distribution wide 2.8 --- 1.4 --- ---
B- Plateletcrit 11.9 --- 6.0 --- ---
U- Porphobilinogen 17.0 31.0 8.5 8.8 22.9
U- Porphyrins 40.0 --- 20.0 --- ---
(B)Leuc- Potassium 13.6 13.4 6.8 4.8 16.0
S- Potassium 4.8 5.6 2.4 1.8 5.8
U- Potassium, concentration, 24h
27.1 23.2 13.6 8.9 31.3
U- Potassium, output 24.4 22.2 12.2 8.2 28.4
S- Prealbumin 10.9 19.1 5.5 5.5 14.5
S- Procollagen type 1 C-terminal 7.8 --- 3.9 --- ---
S- Procollagen type 1 N-terminal 6.8 18.4 3.4 4.9 10.5
S- Prolactin (men) 6.9 61.2 3.5 15.4 21.1
P- Prolyl endopeptidase 16.8 13.9 8.4 5.5 19.3
S- Properdin factor B 9.5 11.2 4.7 3.7 11.5
S- Prostatic specific antigen (PSA) 18.1 72.4 9.1 18.7 33.6
S- Protein C 5.8 55.2 2.9 13.9 18.7
P- Protein S 5.8 63.4 2.9 15.9 20.7
U- Protein, concentration, 24h 39.6 17.8 19.8 10.9 43.5
U- Protein, output, 24h
35.5 23.7 17.8 10.7 40.0
S- Protein, total 2.7 4.0 1.4 1.2 3.4
P- Prothrombin time 4.0 6.8 2.0 2.0 5.3
U- Pyridinoline/creatinine, morning spot 8.7 17.6 4.4 4.9 12.1
B- Pyruvate 15.2 13.0 7.6 5.0 17.5
B- Red cell distribution wide (RDW) 3.5 5.7 1.8 1.7 4.6
S- Reticulocyte highly fluorescent, count 10.0 62.0 5.0 15.7 24.0
S- Reticulocyte low fluorescent, count 1.6 4.9 0.8 1.3 2.6
S- Reticulocyte medium fluorescent, count 13.0 33.0 6.5 8.9 19.6
S- Reticulocyte, count 11.0 29.0 5.5 7.8 16.8
P- Retinol 6.2 21.0 3.1 5.5 10.6
S- Retinol 13.6 19.0 6.8 5.8 17.1
S- Rheumatoid factor 8.5 24.5 4.3 6.5 13.5

Note on abbreviations:
CVw = within-subject biologic variation
CVg = between-subject biologic variation
I = desirable specification for imprecision
B = desirable specification for inaccuracy
TE = desirable specification for allowable total error


 

Analyte Biological
Variation
Desirable
specification

CVw

:intraindivid

CVg

:interindivi

I(%)

:infidelite

B(%)

: biais

TE(%)

erreur totale

S- SCC antigen 39.4 35.7 19.7 13.3 45.8
P- Selenium 12.0 14.0 6.0 4.6 14.5
B- Selenium 12.0 12.0 6.0 4.2 14.1
Semen- Semen, concentration 26.8 56.4 13.4 15.6 37.7
Semen- Semen, morphology 19.6 44.0 9.8 12.0 28.2
Semen- Semen, progressive motility 15.2 32.8 7.6 9.0 21.6
Semen- Semen, progressive rapid motility 18.8 51.8 9.4 13.8 29.3
Semen- Semen, total motility 18.4 29.8 9.2 8.8 23.9
Semen- Semen, vitality 10.3 25.8 5.2 6.9 15.4
S- Sex hormone binding globulin (SHBG) 12.1 42.7 6.1 11.1 21.1
(B)Erythr- Sodium 1.8 12.4 0.9 3.1 4.6
(B)Leuc- Sodium 51.0 36.4 25.5 15.7 57.7
S- Sodium 0.7 1.0 0.4 0.3 0.9
S- Sodium Bicarbonate 4.8 4.7 2.4 1.7 5.6
Sweat- Sodium Chloride 15.0 25.0 7.5 7.3 19.7
U- Sodium, concentration, 24 h. 24.0 26.8 12.0 9.0 28.8
U- Sodium output, 24 h. 28.7 16.7 14.4 8.3 32.0
P- Soluble CD163 9.0 35.9 4.5 9.3 16.7
S- Soluble CD163 4.5 4.5 2.3 1.6 5.3
S- Superoxide dismutase 17.1 10.5 8.6 5.0 19.1
(B)Erythr- Superoxide dismutase 12.3 4.9 6.2 3.3 13.5
S- Testosterone 9.3 23.7 4.7 6.4 14.0
Saliva- Testosterone 17.3 28.8 8.7 8.4 22.7
U- Testosterone 25.0 --- 12.5 --- ---
S- Thyroglobulin 14 39 7.0 10.4 21.9
S- Thyroglobulin antibody 8.5 82.0 4.3 20.6 27.6
S- Thyroid peroxidase antibody 11.3 147.0 5.7 36.9 46.2
S- Thyroid stimulating hormone (TSH) 19.3 24.6 9.7 7.8
23.7
S- Thyrotropin receptor antibody 4.8 --- 2.4 --- ---
S- Thyroxine binding globulin (TBG) 4.4 12.6 2.2 3.3 7.0
S- Thyroxine (T4) 4.9 10.9 2.5 3.0 7.0
S- Tissue polypeptide antigen (TPA) 28.7 40.4 14.4 12.4 36.1
S- Tissue polypeptide specific antigen (TPS) 36.1 108.0 18.1 28.5 58.3
S- Total carnitine 7.7 13.8 3.9 4.0 10.3
U- Total catecolamines, concentration, 24h 24.0 32.0 12.0 10.0 29.8
U- Total porphyrins 40.0 --- 20.0 --- ---
S- Transferrin 3.0 4.3 1.5 1.3 3.8
S- Triglyceride 20.9 37.2 10.5 10.7 27.9
S- Triiodothyronine (T3) 8.7 17.2 4.4 4.8 12.0
S- Troponin I 14.0 63.0 7.0 16.1 27.7
S- Tumor Necrosis Factor-a 43.0 29.0 21.5 13.0 48.4
S- Urate 9.0 17.6 4.5 4.9 12.4
U- Urate, concentration, 24h 24.7 22.1 12.4 8.3 28.7
U- Urate, output, 24h 18.5 14.4 9.3 5.9 21.1
S- Urea 12.3 18.3 6.2 5.5 15.7
U- Urea, concentration, 24h 22.7 25.9 11.4 8.6 27.3
U- Urea, output, 24h 17.4 25.4 8.7 7.7 22.1
U- Vanilmandelic Acid concentration, 24h 22.2 47.0 11.1 13.0 31.3
S- Vascular cell adhesion molecule-1 5.2 16.0 2.6 4.2 8.5
S- Vascular endotelial growth factor 14.1 28.8 7.1 8.0 19.6
P- Vitamin B1 4.8 12.0 2.4 3.2 7.2
B- Vitamin B2 (Riboflavin) 5.8 10.0 2.9 2.9 7.7
(B)Eryth- Vitamin B2 (Riboflavin) 6.4 11.0 3.2 3.2 8.5
(B)Eryth- Vitamin B2 status (gluthation reductase activation) 5.2 40.0 2.6 10.1 14.4
(B)Eryth- Vitamin B12 15.0 69.0 7.5 17.7 30.0
(B)Eryth- Vitamin B6 14.0 24.0 7.0 6.9 18.5
B- Vitamin B6 20.0 34.0 10.0 9.9 26.4
(B)Eryth- Vitamin B6 status (AST activation) 1.4 44.0 0.7 11.0 12.2
(B)Eryth- Vitamin E (a-Tocopherol) 7.6 21.0 3.8 5.6 11.9
(B)Eryth- Vitamin K (Phylloquinone) 38.0 44.0 19.0 14.5 45.9
S- VLDL Cholesterol 27.6 --- 13.8 --- ---
P- Von Willebrand factor 0.001 28.3 0.0005 7.1 7.1
P- Von Willebrand factor antigen 5.0 18.0 2.5 4.7 8.8
S- Water 3.1 0.1 1.6 0.8 3.3
S- Zeaxanthine 34.7 --- 17.4 --- ---
S- Zinc 9.3 9.4 4.7 3.3 11.0
P- Zinc 11.0 14.0 5.5 4.5 13.5